-
1
-
-
33750529518
-
Death receptor 4 variants and colorectal cancer risk
-
1:CAS:528:DC%2BD28XhtVGktbbO 17035413 10.1158/1055-9965.EPI-06-0053
-
Frank B, Shanmugam KS, Beckmann L, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B (2006) Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 15:2002-2005
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, pp. 2002-2005
-
-
Frank, B.1
Shanmugam, K.S.2
Beckmann, L.3
Hemminki, K.4
Brenner, H.5
Hoffmeister, M.6
Chang-Claude, J.7
Burwinkel, B.8
-
2
-
-
0037444387
-
Death receptor 4 and bladder cancer risk
-
1:CAS:528:DC%2BD3sXit1Sgt78%3D 12649168
-
Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X (2003) Death receptor 4 and bladder cancer risk. Cancer Res 63:1157-1159
-
(2003)
Cancer Res
, vol.63
, pp. 1157-1159
-
-
Hazra, A.1
Chamberlain, R.M.2
Grossman, H.B.3
Zhu, Y.4
Spitz, M.R.5
Wu, X.6
-
3
-
-
39449093139
-
The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases
-
1:CAS:528:DC%2BD1cXjtFemurw%3D 18163425 10.1002/pros.20682
-
Langsenlehner T, Langsenlehner U, Renner W, Kapp KS, Krippl P, Hofmann G, Clar H, Pummer K, Mayer R (2008) The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases. Prostate 68:264-268
-
(2008)
Prostate
, vol.68
, pp. 264-268
-
-
Langsenlehner, T.1
Langsenlehner, U.2
Renner, W.3
Kapp, K.S.4
Krippl, P.5
Hofmann, G.6
Clar, H.7
Pummer, K.8
Mayer, R.9
-
4
-
-
69249116239
-
TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis
-
1:CAS:528:DC%2BD1MXhtVKls7jN 19643596 10.1016/j.ejca.2009.06.023
-
Chen B, Liu S, Wang XLXW, Li Y, Zhao WH, Wu JQ (2009) TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis. Eur J Cancer 45:2598-2605
-
(2009)
Eur J Cancer
, vol.45
, pp. 2598-2605
-
-
Chen, B.1
Liu, S.2
Wang, X.3
Li, Y.4
Zhao, W.H.5
Wu, J.Q.6
-
5
-
-
33644850571
-
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer
-
1:CAS:528:DC%2BD28XislKlsbw%3D 16217763 10.1002/ijc.21502
-
Wolf S, Mertens D, Pscherer A, Schroeter P, Winkler D, Gröne HJ, Hofele C, Hemminki K, Kumar R, Steineck G, Döhner H, Stilgenbauer S, Lichter P (2006) Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer. Int J Cancer 118:1831-1835
-
(2006)
Int J Cancer
, vol.118
, pp. 1831-1835
-
-
Wolf, S.1
Mertens, D.2
Pscherer, A.3
Schroeter, P.4
Winkler, D.5
Gröne, H.J.6
Hofele, C.7
Hemminki, K.8
Kumar, R.9
Steineck, G.10
Döhner, H.11
Stilgenbauer, S.12
Lichter, P.13
-
6
-
-
9144272267
-
Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms
-
1:CAS:528:DC%2BD2MXjslSisw%3D%3D 15531454
-
Fernandez V, Jares P, Bea S, Salaverria I, Guino E, de Sanjosé S, Colomer D, Ott G, Montserrat E, Campo E (2004) Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Haematologica 89:1322-1331
-
(2004)
Haematologica
, vol.89
, pp. 1322-1331
-
-
Fernandez, V.1
Jares, P.2
Bea, S.3
Salaverria, I.4
Guino, E.5
De Sanjosé, S.6
Colomer, D.7
Ott, G.8
Montserrat, E.9
Campo, E.10
-
7
-
-
17744364468
-
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma
-
1:CAS:528:DC%2BD3MXhtFSmtro%3D 11313970 10.1038/sj.onc.1204103
-
Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, Kang CS, Kim KM, Jang JJ, Nam SW, Lee JY, Yoo NJ (2001) Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene 20:399-403
-
(2001)
Oncogene
, vol.20
, pp. 399-403
-
-
Lee, S.H.1
Shin, M.S.2
Kim, H.S.3
Lee, H.K.4
Park, W.S.5
Kim, S.Y.6
Lee, J.H.7
Han, S.Y.8
Park, J.Y.9
Oh, R.R.10
Kang, C.S.11
Kim, K.M.12
Jang, J.J.13
Nam, S.W.14
Lee, J.Y.15
Yoo, N.J.16
-
8
-
-
80052288772
-
Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor
-
20443055 10.1007/s10549-010-0900-5
-
Pal R, Gochhait S, Chattopadhyay S, Gupta P, Prakash N, Agarwal G, Chaturvedi A, Husain N, Husain SA, Bamezai RN (2011) Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor. Breast Cancer Res Treat 126:333-343
-
(2011)
Breast Cancer Res Treat
, vol.126
, pp. 333-343
-
-
Pal, R.1
Gochhait, S.2
Chattopadhyay, S.3
Gupta, P.4
Prakash, N.5
Agarwal, G.6
Chaturvedi, A.7
Husain, N.8
Husain, S.A.9
Bamezai, R.N.10
-
9
-
-
84859887213
-
Role of GSTT1 and M1 null genotypes as risk factors for B-cell lymphoma: Influence of geographical factors and occupational exposure
-
1:CAS:528:DC%2BC38XlsFyhtbw%3D 21681823 10.1002/mc.20814
-
Ruiz-Cosano J, Conesa-Zamora P, González-Conejero R, Pérez-Ceballos E, Martínez-Francés A, Vicente V, Pérez-Guillermo M (2012) Role of GSTT1 and M1 null genotypes as risk factors for B-cell lymphoma: influence of geographical factors and occupational exposure. Mol Carcinog 51:508-513
-
(2012)
Mol Carcinog
, vol.51
, pp. 508-513
-
-
Ruiz-Cosano, J.1
Conesa-Zamora, P.2
González-Conejero, R.3
Pérez-Ceballos, E.4
Martínez-Francés, A.5
Vicente, V.6
Pérez-Guillermo, M.7
-
10
-
-
84870661648
-
Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis
-
1:CAS:528:DC%2BC38XltVKltrw%3D 22480748 10.1016/j.jbspin.2012.02.003
-
Morales-Lara MJ, Cañete JD, Torres-Moreno D, Hernández MV, Pedrero F, Celis R, García-Simón MS, Conesa-Zamora P (2012) Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis. Joint Bone Spine 79:591-596
-
(2012)
Joint Bone Spine
, vol.79
, pp. 591-596
-
-
Morales-Lara, M.J.1
Cañete, J.D.2
Torres-Moreno, D.3
Hernández, M.V.4
Pedrero, F.5
Celis, R.6
García-Simón, M.S.7
Conesa-Zamora, P.8
-
11
-
-
64149129845
-
A partition-ligation-combination-subdivision em algorithm for haplotype inference with multiallelic markers: Update of the SHEsis
-
Accessed 12 Jan 2013
-
Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y (2009) A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res 19:519-23. http://analysis2.bio-x.cn/myAnalysis.php. Accessed 12 Jan 2013
-
(2009)
Cell Res
, vol.19
, pp. 519-523
-
-
Li, Z.1
Zhang, Z.2
He, Z.3
Tang, W.4
Li, T.5
Zeng, Z.6
He, L.7
Shi, Y.8
-
12
-
-
0030999555
-
A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
-
1:CAS:528:DyaK2sXjtVSiu7o%3D 9140409 10.1038/ng0497supp-417
-
Mitelman F, Mertens F, Johansson B (1997) A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417-474
-
(1997)
Nat Genet
, vol.15
, pp. 417-474
-
-
Mitelman, F.1
Mertens, F.2
Johansson, B.3
-
13
-
-
0029904295
-
DNA copy number changes in diffuse large B-cell lymphoma - Comparative genomic hybridization study
-
1:CAS:528:DyaK28XjsFGitLw%3D 8652842
-
Monni O, Joensuu H, Franssila K, Knuutila S (1996) DNA copy number changes in diffuse large B-cell lymphoma - comparative genomic hybridization study. Blood 87:5269-5278
-
(1996)
Blood
, vol.87
, pp. 5269-5278
-
-
Monni, O.1
Joensuu, H.2
Franssila, K.3
Knuutila, S.4
-
14
-
-
67749097763
-
Common genetic variants in candidate genes and risk of familial lymphoid malignancies
-
1:CAS:528:DC%2BD1MXhtFSqsbzL 19573080 10.1111/j.1365-2141.2009.07790.x
-
Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR (2009) Common genetic variants in candidate genes and risk of familial lymphoid malignancies. Br J Haematol 146:418-423
-
(2009)
Br J Haematol
, vol.146
, pp. 418-423
-
-
Liang, X.S.1
Caporaso, N.2
McMaster, M.L.3
Ng, D.4
Landgren, O.5
Yeager, M.6
Chanock, S.7
Goldin, L.R.8
-
15
-
-
79955835059
-
Pathogenesis of non-Hodgkin's lymphoma
-
1:CAS:528:DC%2BC3MXotFWmt7s%3D 21483013 10.1200/JCO.2010.33.3252
-
Nogai H, Dörken B, Lenz G (2011) Pathogenesis of non-Hodgkin's lymphoma. J Clin Oncol 29:1803-1811
-
(2011)
J Clin Oncol
, vol.29
, pp. 1803-1811
-
-
Nogai, H.1
Dörken, B.2
Lenz, G.3
-
16
-
-
34547653954
-
Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20
-
1:CAS:528:DC%2BD2sXotlGqu70%3D 17671142 10.1158/1078-0432.CCR-07-0680
-
Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS (2007) Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20. Clin Cancer Res 13:4556-4564
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4556-4564
-
-
Maddipatla, S.1
Hernandez-Ilizaliturri, F.J.2
Knight, J.3
Czuczman, M.S.4
-
17
-
-
78649852204
-
Development of antibody surrogates for the treatment of cancers and autoimmune disease
-
1:CAS:528:DC%2BC3cXhsFamur7K 3050540 20674470 10.1016/j.cbpa.2010.07.002
-
Kodadek T (2010) Development of antibody surrogates for the treatment of cancers and autoimmune disease. Curr Opin Chem Biol 14:721-727
-
(2010)
Curr Opin Chem Biol
, vol.14
, pp. 721-727
-
-
Kodadek, T.1
|